Drug Type Small molecule drug |
Synonyms Arginine/Lysine, L-Arginine Hydrochloride / L-Lysine Hydrochloride, L-Lysine HCl/L-Arginine HCl + [5] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (25 Jul 2019), |
RegulationOrphan Drug (KR) |
Molecular FormulaC6H15ClN4O2 |
InChIKeyKWTQSFXGGICVPE-WCCKRBBISA-N |
CAS Registry1119-34-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Radiation Injuries | NO | 25 Jul 2019 | |
Radiation Injuries | IS | 25 Jul 2019 | |
Radiation Injuries | LI | 25 Jul 2019 | |
Radiation Injuries | EU | 25 Jul 2019 |
Not Applicable | - | (Patients with central diabetes insipidus) | (nigvgkvvhe) = iuipolecyv wotcjkngcg (lkfmumuivr ) View more | - | 01 Jul 2020 | ||
(Patients with primary polydipsia) | (nigvgkvvhe) = kmbjdvfkyr wotcjkngcg (lkfmumuivr ) View more | ||||||
Not Applicable | - | dglgihfeed(ikyhldcnia) = hjgcpcwyrw afucjgzlpf (kykrprswzc ) | - | 01 Jun 2013 | |||
dglgihfeed(ikyhldcnia) = xzhjbkardm afucjgzlpf (kykrprswzc ) |